Analyst Research: Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

8.94USD
5 Mar 2015
Change (% chg)

-- (--)
Prev Close
$8.94
Open
--
Day's High
--
Day's Low
--
Volume
300
Avg. Vol
5,279,873
52-wk High
$9.83
52-wk Low
$3.34

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Trading Report for (NVAX). A detailed report, including free correlated market analysis, and updates. 5 Mar 2015 Stock Traders Daily 6 20.00
NVAX: Due Diligence Review: Forensic Earnings and Valuation 5 Mar 2015 New Constructs, LLC 9 25.00
Thomson Reuters Stock Report - NOVAVAX, INC. (NVAX-O) 5 Mar 2015 Thomson Reuters Stock Report 11 25.00
ValuEngine Industry Report for Medical-biomed/genetics(NVAX) 2 Mar 2015 ValuEngine, Inc. 10 49.00
"The Economy Matters" Report for NVAX: the economy's impact on NVAX's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 2 Mar 2015 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for NVAX 1 Mar 2015 ValuEngine, Inc. 11 25.00
Novavax Inc 28 Feb 2015 S&P Capital IQ Quantitative Report 10 115.00
NOVAVAX INC (NVAX) Zacks Company Snapshot 26 Feb 2015 Zacks Investment Research Inc. 1 12.00
NOVAVAX INC (NVAX) Zacks Company Snapshot 23 Feb 2015 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: NOVAVAX INC (NVAX) 21 Feb 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

James Young

61 2011 Independent Chairman of the Board

Stanley Erck

66 2011 President, Chief Executive Officer, Director

Barclay Phillips

51 2013 Chief Financial Officer, Senior Vice President, Treasurer

Gregory Glenn

60 2014 Senior Vice President - Research & Development

Sven Andreasson

63 2014 Senior Vice President - Corporate Development
Search Stocks